{"transactions":[{"id":1323786,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2024-12-20T22:15:08.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit is convertible into one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent (50%) of the Restricted Stock Units will vest upon the one (1) year anniversary of the Vesting Commencement Date, and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date."}],"balance_after":225000,"derivative":{"expiration_date":"2034-12-17","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001683168-24-008901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000168316824008901/ownership.xml","form_type":"4"}},{"id":1562964,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-22T22:49:39.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 50% on the first anniversary of the grant date and (ii) the remaining 50% in 12 equal monthly installments over the 12 months thereafter."}],"balance_after":10000,"derivative":{"exercise_price":1.34,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-035555","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000095017024035555/ownership.xml","form_type":"4"}},{"id":1897773,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-05-10T22:43:52.000Z","date":"2023-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the 36 months thereafter."}],"balance_after":100000,"derivative":{"exercise_price":0.13,"expiration_date":"2033-05-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-23-012533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000089924323012533/doc4.xml","form_type":"4"}},{"id":2407768,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-08T22:32:47.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":35000,"derivative":{"exercise_price":1.67,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-22-014161","document":"tm225821d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465922014161/tm225821d1_4.xml","form_type":"4"}},{"id":2469374,"issuer":{"id":8459,"kind":"organization","name":"Valion Bio, Inc.","symbol":"VBIO"},"owners":[{"id":84854,"kind":"person","name":"Gurfein Blake","position":1,"cik":"0001891888","reported_name":"Gurfein Blake","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T01:38:48.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: (i) 25% one year from the grant date, and (ii) the remaining 75% in equal monthly installments over the next 36 months."}],"balance_after":82500,"derivative":{"exercise_price":4.59,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001104659-21-150714","document":"tm2135733d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787740/000110465921150714/tm2135733d4_4.xml","form_type":"4"}}]}